Abstract. Leukocytes and tumor cells use E-selectin binding ligands to attach to activated endothelial cells expressing Eselectin during inflammation or metastasis. The cysteine-rich fibroblast growth factor receptor (CFR) represents the main E-selectin ligand (ESL-1) on granulocytes and its expression is exclusively modified by ·(1,3)-fucosyltransferases IV or VII (FucT4 and FucT7). Hepatic stellate cells (HSC) are pericytes of liver sinusoidal endothelial cells. The activation of HSC and transdifferentiation into a myofibroblastic phenotype is involved in the repair of liver tissue injury, liver regeneration and angiogenesis of liver metastases. In the present study, we demonstrated that HSC expressed CFR together with FucT7 and exhibited a functional E-selectin binding activity on their cell surface. Since HSC appear to be oxygen-sensing cells, the expression of E-selectin binding activity was analyzed in HSC under a hypoxic atmosphere. While the expression of the glycoprotein CFR was unaffected by hypoxia, the cellassociated E-selectin binding activity decreased. However, under the same conditions, mRNA expression of the modifying enzyme FucT7 increased. The loss of E-selectin binding activity, therefore, appears to be neither the result of a reduced expression of the modifying transferase nor the expression of the backbone glycoprotein. After the transient transfection of HSC with CFR cDNA, the E-selectin binding activity (ESL-1) was efficiently released into the supernatant. Therefore, we hypothesize that under hypoxia, ESL-1 is shed from activated HSC. Our findings provide a novel perspective on the function of HSC in liver metastasis and inflammatory liver diseases.
Introduction
Hepatic stellate cells (HSC) are pericytes of liver sinusoidal endothelial cells. HSC contact hepatocytes and endothelial cells via long cytoplasmic processes, which may be important for cell-cell communication and the structural (re)organization of the hepatic sinusoidal compartment. The activation of HSC and transdifferentiation into a myofibroblastic phenotype (MFB, myofibroblasts) appear to be involved in the repair of liver tissue injury, regeneration and angiogenesis of liver metastases (1, 2) .
The entry of leukocytes as well as tumor cells is controlled by cell adhesion particularly between the invading and endothelial cells. The cytokine-inducible E-selectin mediates the binding of neutrophils to endothelial cells and is implicated in colon cancer metastasis (3) .
E-selectin is a calcium-dependent type-I transmembrane glycoprotein with an extracellular lectin-like domain that interacts with sialylated carbohydrates. E-selectin is synthesized by activated endothelial cells and mediates the initial tethering of circulating blood cells with endothelial cells. Its expression is transcriptionally up-regulated by several factors including tumor necrosis factor (TNF), interleukin (IL)-1, nuclear factor κB (NF-κB) and under hypoxia (4, 5) .
Binding to E-selectin depends on the presence of sialylated and fucosylated carbohydrate structures (sialyl Lewis xlike) which are generated by ·(1,3)-fucosyltransferases (FucT) (6) . E-selectin ligand-1 (ESL-1), P-selectin glycoprotein ligand-1 (PSGL-1) and CD44 represent E-selectin ligand activities on neutrophils. While PSGL-1 plays a major role in the initial leukocyte capture, ESL-1 is critical for converting initial tethers into steady slow rolling (7) .
ESL-1 is the major E-selectin ligand on neutrophils and solely binds to E-selectin. Its expression is almost exclusively modified by FucT4 and FucT7. ESL-1 is identical to the cysteine-rich fibroblast growth factor receptor (CFR) and the membrane sialoglycoprotein of the medial cisternae of the Golgi complex, MG-160. The gene-encoding ESL-1/CFR is known as GLG1 (Golgi complex-localized glycoprotein-1) (8 to adhere to endothelial and stromal cells after extravasation (9) . In an experimental hepatic metastasis model, HSC, the only mesenchymal cells present in the extravascular space of the sinusoidal compartment, demonstrated a close interaction with colon carcinoma cells (10) . The adhesion molecules involved in this interaction are unknown thus far but may be potential targets for new therapeutic strategies.
In this study, we analyzed the expression of CFR/ESL-1, fucosyltransferases and E-selectin in primary HSC and in in vitro transdifferentiated/activated HSC. We investigated their gene expression under hypoxia which represents the microenvironmental atmosphere present in inflamed tissue and in tissue infiltrated by rapidly growing tumor cells.
To the best of our knowledge, the expression of E-selectin has thus far been exclusively reported on endothelial cells. Herein, we reported the expression of E-selectin and its ligand ESL-1 by HSC. Notably, under hypoxia, FucT7 was up-regulated and accompanied by a strong induction of the E-selectin expression.
Materials and methods

Preparation of cells.
Rat HSC were prepared from male Sprague-Dawley rats by the pronase/collagenase method as previously described (11) . The mean purity was >95% and the yield ranged from 25 to 50x10 6 cells/liver. Activated rat HSC/myofibroblasts (MFB) were generated by secondary cultures of trypsinized 7-day-old primary HSC. Rat HSC and MFB were cultured in DMEM supplemented with 10% FCS (11) .
The human HSC line LX-2 (which was a kind gift from Dr S.L. Friedman, Mount Sinai Medical School, New York, NY) was kept at 2% FCS. Cells were routinely cultured in humidified 95% air (20% O 2 ) and 5% CO 2 at 37˚C. For the hypoxic stimulation, cells were serum-starved (0.5% FCS) for 24 h and subsequently placed in an Invivo2 hypoxia incubator (Invivo2 hypoxia workstation 400, Ruskinn Technology Guiseley Leeds, UK) and flushed with gas (0.5% O 2 , 5% CO 2 and 94.5% N 2 ) for 48 h.
RNA isolation and RT-PCR analysis.
Total RNA from LX-2 cells was extracted by using the RNeasy mini kit (Qiagen, Hilden, Germany). RNA from primary rat HSC was extracted with the RNeasy lipid tissue mini kit (Qiagen) according to the manufacturer's instructions. Of the total extracted RNA, 1 μg was reverse transcribed with an omniscript reverse transcriptase kit (Qiagen) using oligo dT as a primer. cDNAs were amplified using the Taq DNA polymerase kit from Qiagen. PCR primers were obtained from Invitrogen (Heidelberg, Germany). The primer pairs for PCR-analysis were: 5'-GTC CAG TTG TAA GTT CTC CTC TGA-3' (E-sel forward), 5'-GCA AGC AAA ATA TAA ATC CCG GTC-3' (E-sel reverse), 5'-GAA GAG TCC TGC AGG GAG GAC-3' (GLG1 forward), 5'-GCA AGC AAA ATA TAA ATG CCG GTC-3' (GLG1 reverse), 5'-TCA CCA TCC TTG TCT GGC ACTG-3' (FucT7 forward), 5'-GCT CAG CAC CCA GTT GAA GAT G-3' (FucT7 reverse), 5'-CG CTG GGT TTG GAT GAA CTT CGA-3' (FucT4 forward), 5'-ACT TGG GAA GTC GTC CAC GTG GAT G A-3' (FucT4 reverse), 5'-CTC TGG CAT AAT CCT TAC GAC-3' (decorin forward) and 5'-GGT ATG CAA GTC CTT CAG GTT C-3' (decorin reverse). The rat primers used for the amplification of VEGF and rpS6 have been published before (11) . To confirm the specificity of the amplification, PCR products were DNA sequenced using the big dye terminator v1.1 cycle sequencing kit and an ABI PRISM 310 genetic analyzer (Applied Biosystems, Weiterstadt, Germany).
Northern blot analysis. Total RNA isolated from monolayer cultures was separated using 1% formaldehyde agarose gels and blotted onto a nylon membrane (Hybond N + , Amersham Pharmacia Biotech, Buckinghamshire, UK). cDNA probes for hybridization were prepared by labeling a 606 bp purified PCR fragment of the rat CFR cDNA with [ 32 P]dCTP using a random primer labeling system (Invitrogen).
Immunofluorescence. Three-day old rat HSC and MFB were cultured on glass coverslips coated with polylysine or collagen at a density of 2x10 4 cells/35-mm dish. For immunostaining, cells were fixed with 4% (w/v) paraformaldehyde in PBS. Non-specific binding sites were blocked with 3% (v/v) bovine serum albumin (BSA) in PBS. Cells were incubated with a recombinant mouse E-selectin/human immunoglobulin chimera (R&D Systems, Wiesbaden, Germany). The immunocomplexes were detected using an appropriated fluorescence dye-conjugated secondary antibody. The cells were mounted in 90% glycerol containing p-phenylenediamine and viewed with a 63x oil immersion lens on a Zeiss microscope equipped with barrier filters for fluorescein.
Immunoblot analysis. The procedures used for preparing cell lysates have been described in detail elsewhere (11) . Samples from equivalent numbers of cells were fractionated by SDS-PAGE in 12.5% gels, transferred to nitrocellulose membranes (Schleicher & Schuell), probed with a recombinant mouse Eselectin/human immunoglobulin chimera or with a rabbit polyclonal antiserum kindly provided by C.J. Dimitroff (Harvard Institute of Medicine, Boston, MA). Subsequently, horseradish peroxidase-linked secondary antibodies (Pierce) were added and immunocomplexes were detected by enhanced chemiluminescence (Pierce).
Statistical analysis. Statistical analyses were performed using SPSS version 10.0 (SPSS, Chicago, IL, USA). Results are expressed as mean ± SD (range). A comparison between the groups was made using the Student's unpaired t-test. P-values <0.01 and <0.05 were considered significant.
Results
The E-selectin ligand-1/CFR-encoding gene GLG1 is expressed in freshly isolated and activated HSC. Expression of the E-selectin ligand-1/CFR-encoding gene GLG1/CFR was analyzed in hepatic stellate cells (HSC) at different time points during in vitro activation/transdifferentiation to myofibroblasts (MFB) by RT-PCR (Fig. 1A) . The identity of the PCR fragments was confirmed by DNA sequencing. GLG1 was clearly detectable in all cells analyzed and did not appear to be differentially expressed during the in vitro activation process of HSC. GLG1 mRNA expression was further examined by Northern blot analysis, revealing two transcripts of the expected size of ~3 and 8 kb, respectively (Fig. 1B) . GLG1 gene expression levels also appeared invariant in HSC due to Northern blot analysis during the course of transdifferentiation into myofibroblasts. ·(1,3) -fucosyltransferase VII. The E-selectin ligand activity correlates with the selective generation of the sialyl Lewis x-like epitope and the HECA452-reactive carbohydrate epitope, which depends on the expression of the ·(1,3)-fucosyltransferase IV (FucT4) or VII (FucT7). In cells expressing FucT4 or FucT7, CFR/ESL-1 is the preferred target protein for the generation of E-selectinbinding carbohydrate modifications (6) . Therefore, RNA expression of candidate fucosyltransferases was analyzed by RT-PCR in HSC at different time points during the in vitro activation. An increased mRNA expression of FucT7 was found during the in vitro transdifferentiation of HSC. The amplified PCR fragments have been confirmed by DNA sequencing. In contrast to the human HSC cell line, LX-2, which expressed FucT4 and FucT7 transcripts, FucT4 mRNA was not detected in rat HSC regardless of the activation stage ( Fig. 2A) .
HSC and MFB express the
The E-selectin encoding gene is expressed in HSC and downregulated in MFB.
Since HSC interact with hepatocytes and endothelial cells during the early phases of liver regeneration, and with cancer cells and leukocytes under pathological conditions including metastasis and inflammation, cells known to express E-selectin-binding sites, we investigated the RNA expression of E-selectin by HSC and MFB. Notably, RT-PCR showed that HSC and MFB expressed E-selectin transcripts.
A semiquantitative RT-PCR analysis with limited cycles demonstrated a clear down-regulation of E-selectin mRNA in MFB compared to the freshly isolated HSC (Fig. 2A, lower  panel) . The amplification of the GLG1/CFR transcript was used as an internal control. The amplified PCR fragments have been confirmed by DNA sequencing.
E-selectin ligand is expressed on HSC and MFB.
To investigate the surface expression of the functional E-selectin binding activity on HSC during the course of in vitro activation, immunofluorescence was performed with cells grown on cover slips coated with collagen or polylysine. Cells were fixed and incubated with a mouse E-selectin human Ig chimera. Although during in vitro transdifferentiation the transcription of GLG1 seems to be invariant and FucT7 is increased, respectively, activated HSC/MFB appeared to have less E-selectin ligands present on their cell surface than did HSC three days after isolation, and this appears to be independent of the cell culture substrate (Fig. 2B-D) .
The up-regulation of E-selectin and ·(1,3)-fucosyltransferase
VII in HSC by hypoxia. During liver repair processes, the inflammatory affection of the sinusoidal compartment and of liver metastasis HSC have to cope with a hypoxic environment and are considered as hypoxia-sensitising cells (12) . Therefore, we cultured HSC under normal atmospheric oxygen and hypoxic conditions to study gene expression. After 3 days in the culture under normal atmospheric oxygen conditions HSC exhibited the typical stellate-like cell morphology with lipid droplets (Fig. 3A) and all cells showed the typical auto- fluorescence-associated vitamin-A storage (Fig. 3B) . Under the hypoxic atmosphere a significant part of the cells showed an elongated, fibroblast-like cell morphology ( Fig. 3C and D, enlarged section). Some of these activated HSC had already lost their lipid droplets (Fig. 3D) . We then investigated gene expression in cultured HSC under normal atmospheric oxygen and hypoxic conditions using RT-PCR techniques.
The RT-PCR analysis showed a marked increase in the gene expression of E-selectin (14-fold) and Fuct7 (2.5-fold) in hypoxic HSC. Accordingly, the known hypoxia-inducible gene VEGF revealed a significant induction (9.7-fold) (Fig. 3F) .
Cell-associated ESL-1 is down-regulated on HSC under hypoxia.
To examine the influence of hypoxia on the expression of E-selectin binding activities and CFR/ESL-1, we immunoblotted extracts prepared from HSC cultured under normal atmospheric oxygen and hypoxic conditions for 48 h, respectively. The membranes were probed with E-selectin human immunoglobulin chimera and with rabbit polyclonal anti-ESL-1 antiserum. Although the protein expression of ESL-1/CFR remained at a constant level (Fig. 4A, lower  panel) , the cell-associated E-selectin binding activity clearly decreased under hypoxia (Fig. 4A, upper panel) . Extracts from the human hematopoietic progenitor cell line KG1a were included as a control. The E-selectin binding activities present on KG1a are represented by CD44 at 100 kDa and PSGL-1 at 130 kDa, while ESL-1/CFR expression was not detected (Fig. 4A) (14) . In contrast, HSC exclusively expressed a single band of 150 kDa corresponding to the E-selectin binding activity.
Previously, we showed that CFR/ESL-1 can be released into the supernatant by COS-1 cells (13). The LX-2 HSC line represents a well-established model of activated HSC. LX-2 cells express ESL1/CFR and particularly the leukocyte fucosyltransferase IV, which is the main Lewis x carbohydratemodifying enzyme in granulocytes (Fig. 4B) . Therefore, we analyzed the cell extracts and supernatant from the LX-2 cells for E-selectin binding activity by immunoblotting with E-selectin immunoglobulin. Cell-associated E-selectin binding activity was detected in the LX-2 cells, but considerably more activity was found in the supernatant, particularly when heparin was included in the medium (Fig. 4C) . To demonstrate that ESL-1 represents the E-selectin binding activity, LX-2 cells were transfected with cDNA encoding the highly conserved chicken CFR which has been His-tagged. In the transfected cells, a slightly more cell-associated E-selectin binding activity was detectable, but considerably more activity was found in the supernatant suggesting that CFR was efficiently modified to ESL-1 in LX-2 cells and was secreted or produced by shedding into the supernatant. The same extracts were analyzed with an anti-His antibody to demonstrate the expression of the transfected cDNA.
Discussion
In the present study, we demonstrated for the first time functional E-selectin binding sites on HSC. Our results suggest that the E-selectin activity expressed by HSC is mainly represented by CFR which is modified by the fucosyltransferase FucT7. A hypoxic atmosphere substantially induced the transcription of the modifying fucosyltransferase FucT7 as well as transcription of E-selectin in HSC. Under hypoxia, ESL-1 appears to be shed from the HSC surface into the supernatant. The soluble form of ESL-1 is still capable of binding to E-selectin, and thus, may compete with cellassociated ESL-1.
Leukocyte recruitment to sites of inflammation involves several types of adhesion molecules and their receptors, the selectins (E-, P-and L-), integrins and members of the immunoglobulin family (14) . According to current models, the first contact between leukocytes and endothelial cells is mediated via selectin-ligand interactions which lead to the attachment and rolling of the leukocytes on the activated endothelial cells. In a very similar way selectins may facilitate cancer metastasis and tumor cell arrest in the sinusoidal vascularisation of the liver. The fast-growing tumor cells create a hypoxic microenvironment which may lead to the transcriptional up-regulation of E-selectin expression in HSC. This mechanism may offer tumor cells which express sialofucosylated oligosaccharides, such as sialyl Lewis x (sLeX), binding sites in addition to endothelial cells. Notably, the overexpression of sLex moieties on tumor cells is correlated with poor prognosis and metastatic spread (5,9).
Since we only detected a single E-selectin-binding band of 150 kDa in HSC, it appears that HSC do not express further E-selectin binding activities such as CD44, CD43 or PSGL-1 (7, 15) . In contrast to HSC, tumor cells often express additional P-, L-and E-selectin ligands such as CD44 and PSGL-1 (9). The up-regulation of E-selectin on activated HSC offers the potential of cell-cell interaction with endothelial and tumor cells. Notably, during the course of tissue repair after partial hepatectomy (PH), hepatocytes and HSC first form avascular cell islands in which endothelial cells are recruited. Mice subjected to PH have a significantly increased number of metastases in experimental metastasis models which appears to depend on the increased E-selectin expression found after PH (16) .
In a previous report, we demonstrated that CFR can be released into the supernatant of COS-1 cells, transiently transfected with a cDNA-endoding CFR (13) . In the present study, we demonstrated that the HSC cell line LX-2 released CFR as an E-selectin binding protein. Hypoxia-activated HSC and MFB express less E-selectin binding activity on their cell surface than do HSC grown under normal atmospheric oxygen conditions (Figs. 2 and 4) . Therefore, cleavage of the protein from the cell surface would be a potential mechanism to explain that under hypoxic conditions cell-associated CFR expression was invariant and the modifying enzyme was transcriptionally up-regulated, while less E-selectin binding activity (ESL-1) was found on the cell surface. Since the soluble ESL-1 exported by LX-2 cells is still capable of binding to E-selectin, soluble ESL-1 may represent a competitor for cellular ESL-1.
Hypoxia-activated HSC is a new cell type expressing Eselectin and may support extravasation of the leukocyte and tumor cells into the space of Disse. It may also be speculated that HSC-derived myofibroblasts and HSC under hypoxia are capable of shedding ESL-1 from their cell surface into the extracellular space. The mode of processing and function of a soluble ESL-1, however, have yet to be elucidated.
